by Karen O'Hanlon Cohrt | Apr 11, 2018 | Trends
In the modern fast-paced worlds of research and medicine, disease models that take us closer to the real-life situation are highly desirable. While we can’t discredit the power of in vitro cell culture methods to provide important clues about biological processes,...
by Olwen Reina | Sep 13, 2016 | Disease Models
What are keratinocytes? Take a look at your hands, your face and your toes. Most of what you’re seeing are your keratinocytes. They make up over 90% of the cells of the epidermis, the outermost layer of the skin. The skin on your neck and the soles of your feet,...
by Karen O'Hanlon Cohrt | Nov 18, 2022 | Trends
Welcome to our new blog series about the blood brain barrier (BBB)! In Part 1, we will give a brief history on the discovery of the BBB, as well as introduce what we know about its composition and biological functions. The blood brain barrier or BBB is a highly...
by Allison Kennedy | May 10, 2023 | Citation Alerts
Tempo-iMG™ was cited in cell.com in a study that investigated HIV-1 integration in the unexplored microglia reservoir that gives rise to continued HIV replication in infected cells. Scientists used Tempo-iMG™ human iPSC-derived microglia to determine that CTCF, an...
by Angela L. Huang | Apr 10, 2019 | News
SAN FRANCISCO, CA —Tempo Bioscience, Inc. (“Tempo”) a privately-held biotechnology company based in San Francisco, California, has released new human induced pluripotent stem cell (iPSC) derived products and affiliated cell-based services in the following categories:...
